Parkinson's Disease Trial, Recruiting (NCT07105787)

Parkinson's Disease Trial, Recruiting NCT07105787 Sponsor: University of Kiel Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07105787 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Parkinson's disease according to recognised medical guidelines
Your Parkinson's symptoms are in the mild to moderate range (stages 1 to 3 out of 5 on a standard scale used by doctors)
You have at least some walking difficulties as measured by a standard Parkinson's assessment tool
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You have a general health condition that could make unsupervised physical exercise unsafe or unsuitable for you
You are experiencing moderate or severe depression, as measured by a standard questionnaire score
You have memory or thinking difficulties that might prevent you from fully understanding and agreeing to take part
You are unable to understand and follow a normal conversation at least 75% of the time
You have a serious mental health condition that might make it hard to follow the study's requirements, or you currently have or have had a dependency on alcohol or drugs
You are unable to walk at least one floor (confirm with trial site)
You have had chest pain in the last 4 weeks
You are currently taking part in another clinical trial that involves a treatment or intervention
You have a deep brain stimulation device already implanted

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07105787

Sponsor: University of Kiel

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

More information: https://clinicaltrials.gov/study/NCT07105787

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Parkinson's disease according to recognised medical guidelines
Your Parkinson's symptoms are in the mild to moderate range (stages 1 to 3 out of 5 on a standard scale used by doctors)
You have at least some walking difficulties as measured by a standard Parkinson's assessment tool
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

You have a general health condition that could make unsupervised physical exercise unsafe or unsuitable for you
You are experiencing moderate or severe depression, as measured by a standard questionnaire score
You have memory or thinking difficulties that might prevent you from fully understanding and agreeing to take part
You are unable to understand and follow a normal conversation at least 75% of the time
You have a serious mental health condition that might make it hard to follow the study's requirements, or you currently have or have had a dependency on alcohol or drugs
You are unable to walk at least one floor (confirm with trial site)
You have had chest pain in the last 4 weeks
You are currently taking part in another clinical trial that involves a treatment or intervention
You have a deep brain stimulation device already implanted

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Kiel

Registry

ClinicalTrials.gov

Start date

31 March 2025

Est. completion

31 March 2026

Where this trial is recruiting

🇮🇱 Israel 🇮🇹 Italy

Primary endpoints

Gait speed - T0; Gait speed - T1; Gait speed - T2

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov